HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Ad Authority Gives Caffeinated Shampoo Maker A Wakeup Call

This article was originally published in The Rose Sheet

Executive Summary

Dr. Kurt Wolff’s study data for Alpecin Caffeine Shampoo is insufficient to support statements about hair-loss reduction, according to the Advertising Standards Authority’s March 28 ruling.

You may also be interested in...



NAD: Firm's Laser Cap Hair-Regrowth Claims Not Supported, Despite FDA Clearance

The Capillus82 Hair Regrowth Laser Cap may be "substantially equivalent" to the manufacturer's Capillus272 Pro device, based on FDA's 510(k) clearance, but NAD says hair-growth clinical findings from that "predicate" device cannot serve to substantiate claims for the untested Capillus82. The case illustrates complexities in the medical device segment, which increasingly is of interest to cosmetics companies.

Hot Chocolate For 'Rapunzel Locks'? UK Ad Watchdog Pounces

The Advertising Standards Authority says Cocoa Locks' hair-growth promises for its hot chocolate mix exceed authorized food health claims registered in the EU. The company’s business may need a major overhaul, down to its brand tagline, “Hair Growth Never Tasted So Good.”

Firm's Discontinued Hair Volume Claims Keep Growing Back; NAD Alerts FTC

New Nordic's seeming refusal to dispense with hair-growth claims in ads for its Hair Volume supplement, despite repeated promises to the National Advertising Division, has resulted in a referral to the Federal Trade Commission.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121541

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel